Literature DB >> 7463326

Suppression of endogenous hydrocortisone with dexamethasone.

T J Goehl, G M Sundaresan, J P Hunt, V K Prasad, R D Toothaker, P G Welling.   

Abstract

A newly developed high-pressure liquid chromatographic method was used to study the optimum dosage regimen needed to suppress endogenous hydrocortisone. Nine volunteers were randomly placed in three groups. Each group received 1 mg of dexamethasone at 11 pm (Treatment A), 2 mg of dexamethasone at 11 pm (Treatment B), or 1 mg at 11 pm and an additional 1 mg at 6 am the following day (Treatment C). Analysis of multiple blood samples obtained the day before and the day after drug administration showed suppression in all three groups. Although the duration and extent of this suppression varied, adequate suppression to permit bioavailability studies was observed for Treatments B and C.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7463326     DOI: 10.1002/jps.2600691214

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression.

Authors:  R D Toothaker; P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1982-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.